Expert Q&A

Search our library of questions and answers below, or submit your own question to our panel of experts.

Questions Answered By Expert

Expert Image

Christina Ha, MD

Director of the Inflammatory Bowel Disease fellowship at Cedars-Sinai Medical Center, Associate Professor

Q: If a patient has been on Azathioprine and balsalazide for 15+ years. What blood tests should be performed for routine monitoring? My husband's GI has been just doing a CBC, but as a result of his yearly physical lab report (with family practice dr.), we learned he has liver impairment. Are regular liver tests standard if you take Azathioprine? Should I be concerned about the level of care he's receiving from his current GI doctor?

A: Thanks for the question – monitoring while on medications is important as we can sometimes pick up on subtle changes and act on them before they become a problem. Balsalazide is generally a very safe and well tolerated medication and doesn’t require strict monitoring like some of the other medications. We do recommend checking kidney function through bloodwork at least every year with something called a metabolic panel or profile. This is because there is a rare condition called acute interstitial nephritis associated with this class of medications – I have to emphasize that this is really uncommon, but it’s simple enough to check kidney function annually with blood work, especially if you are taking other medications that can affect the kidneys or have conditions affecting the kidneys (but you are probably already being monitored for that already. With respect to azathioprine, we do recommend getting routine bloodwork – depending on how long and how stable the dosing regimen has been, it can be every 3-6 months. In my practice, I check a CBC (complete blood count) to monitor the White blood cell count number, which can occasionally be low while on the medicine; the Hemoglobin/Hematocrit (which helps us look for anemia), and the platelets which are a subtle and non-specific marker of inflammation. I also check what’s called a complete metabolic profile to check kidney and liver tests, azathioprine can sometimes increase the liver numbers, so we monitor that as well. Also, we recommend at least annual skin exams while on azathioprine, sun protection and to reapply given the association with an increased risk of skin cancer. hide answer

Q: I'm 25, have Crohn's Disease, and am currently regulating it with diet as I didn't respond well with the different medications. I get sores in my mouth during flare ups, but this time is the worst I have ever experienced. I have sores all along my jaw and cheek inside mouth causing a pretty swollen cheek. It's been like that for almost 2 weeks now. Any suggestions on what to put on the sores or how to get inflammation in cheek to go down?

A: My first thought when reading this is that you may have active Crohn’s disease as oral aphthous ulcers tend to be present during active disease. The first thing I would recommend is to get an evaluation of your disease activity. In terms of addressing the symptoms, mouthwashes or rinses that contain steroids and analgesics such as viscous lidocaine are temporizing measures but treatment of the underlying issue is the key. If there isn’t active Crohn’s disease, other causes can be vitamin/mineral deficiencies – zinc, iron, b12, etc, or viral infections or other autoimmune conditions such as Behcet’s disease. However – I suspect that your Crohn’s disease isn’t as well controlled as it should be and would recommend an evaluation, particularly if you are this symptomatic. hide answer

Q: My son has Crohn's and was on Remicade+MTX from past 5 years. He started with flare-up recently but his Remicade blood levels were normal with no antibodies detected? What does this mean? His blood tests and endoscope showed elevated Eosinophils. Colonoscopy showed inflammation in colon. Does it mean the Remicade became ineffective even with no antibodies? Or could it be due to any other infections or food allergies?

A: It depends on how “normal” the levels are – during active disease, sometime patients require higher dosing and adjustments to still keep them therapeutic. For example, therapeutic is a value > 5, but if someone is symptomatic with a level of 6, they may do better with higher dosing or shortened intervals. If the levels are an acceptable level and there is active disease, then this means that he likely lost response to Remicade/MTX combination – meaning, in simple terms, that his Crohn’s disease outsmarted the medications and he would potentially be better with a medication that works in a different mechanism of action such as vedolizumab (Entyvio) or ustekinumab (Stelara). However, discuss this with your gastroenterologist first. hide answer